Owlet Baby Care, which offers a "connected nursery ecosystem," has announced its merger with Sandbridge Acquisition Corporation, a special purpose acquisition company. 

The deal will bring $325 million to the combined company, which will primarily fuel an expansion into the growing telehealth industry. 

"Owlet's really sitting at the intersection of two massive trends: the consumerization of healthcare technology and the digitization of professional services," Kurt Workman, CEO of Owlet, told Cheddar. 

Owlet's anchor product is the Smart Sock, which collects data such as heart rate, oxygen, skin temperature, and sleep quality from infants while they're sleeping. Parents can then see that information each morning in the form of sleep reports. 

The growth potential of innovating in infant-care and health management is what attracted Sandbridge to the company. 

"When we look at brands for Sandbridge, we always look at disruption," said Ken Suslow, chairman and CEO of Sandbridge Acquisition Corporation. 

"In this case, it was really obvious that when we looked at Owlet that this was a high-growth brand that was disrupting the nursery, an area that's had no disruption for decades."

Suslow noted that the core business has also been growing at 50 percent a year. 

The company's long-term goal is to employ products such as its BabySat, an infant pulse oximeter, for babies with health conditions, that has not yet received FDA approval, and an over-the-counter version of the Smart Sock in telehealth screenings. 

Suslow added that the capital will help hire new engineering talent and pay for marketing. 

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More